Skip to main content
. 2022 Dec 16;18(4):974–987. doi: 10.1177/19322968221144052

Table 3.

CGM Eligibility Criteria for Selected States.

Criteria T1D T2D GDM ≥3 daily injections or insulin pump a BGM ≥4 times daily HbA1c ≥7% b Frequent severe hypo (<50mg/dL) Hypoglycemia unawareness History of hyperglycemia c Nocturnal hypoglycemia DKA Preprandial-postprandial hyperglycemia Dawn phenomenon Benefit
Arkansas Yes Yes Yes Yes Yes DME
Georgiad,e Yes Yes Yes Yes Yes Yes Yes DME
Idaho Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes DME
Kentucky a Yes Yes Rx
Michigan Yes Yes Yes Yes Yes DME
Missouri Yes Yes f Yes f Yes a Rx
Nevada Yes Yes Yes Yes Yes Yes Yes Rx
New Hampshire Yes Yes Yes Yes Yes Yes Rx
New York e Yes Yes Yes Yes Yes Rx
Oklahoma Yes Yes Yes Yes Yes Yes Yes Yes Yes Rx
Rhode Island Yes Yes Yes Yes Yes DME

Abbreviations: CGM, continuous glucose monitoring; GDM, gestational diabetes; BGM, blood glucose monitoring; HbA1c, glycated hemoglobin; DKA, diabetic ketoacidosis; DME, Durable Medical Equipment; Rx, pharmacy benefit.

a

≥3 times daily or insulin pump which may require frequent adjustments.

b

Or not achieving target HbA1c.

c

Including unexplained hyperglycemia.

d

Pediatric coverage only.

e

Prescription by an endocrinologist.

f

Use of rapid-acting insulin is required.